ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Bristol-Myers puts up Opdivo-plus-Yervoy data, adding to combo-therapy mystery
August 17, 2017Opdivo, a PD-1 checkpoint inhibitor, and its fellow Bristol-Myers immunotherapy Yervoy are in testing in a variety of cancers, and analysts are watching to see if combining a PD-1 med with a CTLA4 therapy beats out PD-1/L1 chemo combos. -
China’s Zai Lab files for $115M Nasdaq IPO to take Tesaro, Bristol-Myers cancer drugs through late-p
August 17, 2017A slice of the Zai Lab IPO haul is earmarked for trials of Tesaro's niraparib. -
Bristol-Myers sells clinical manufacturing facility to Seattle Genetics
August 07, 2017Bristol-Myers Squibb is unloading a clinical materials manufacturing facility and labs in Washington to Seattle Genetics, which has agreed to keep on the workers employed there. -
Bristol-Myers to buy IFM Therapeutics
August 07, 2017Bristol-Myers Squibb Co said it would buy privately held IFM Therapeutics for an upfront payment of $300 million
Pharma Sources Insight January 2025
